PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Cash Flow (Statement)
-$10.41M
Quarterly · Period ending: · USD
PHAS Operating Cash Flow (Statement)
Latest reported-$10.41Mperiod ending
Latest reported-$10.41Mperiod ending
PHAS Quarterly Cash from Operations (-$2.09M → -$10.41M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
PHAS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -10,411,000 | |
| -22,884,000 | |
| -19,994,000 | |
| -6,132,000 | |
| -11,090,000 | |
| -10,200,000 | |
| -11,345,000 | |
| -15,827,000 | |
| -8,958,000 | |
| -23,827,000 | |
| -12,489,000 | |
| -8,240,000 | |
| -10,134,000 | |
| -8,731,000 | |
| -6,838,000 | |
| -3,576,000 | |
| -4,005,000 | |
| -2,634,000 | |
| -2,424,000 | |
| -2,090,000 |